TipRanks
Xenon (DE:XP0)
FRANKFURT:XP0
Germany Market
XP0
Xenon
RESEARCH TOOLSreports

Xenon (XP0) Stock News & Sentiment

0 Followers
Minter Reiterates Buy on Xenon as Azetukalner NDA Progress and Manageable Neuropsychiatric Risk Underscore Favorable Risk‑Reward
Premium
Ratings
Minter Reiterates Buy on Xenon as Azetukalner NDA Progress and Manageable Neuropsychiatric Risk Underscore Favorable Risk‑Reward
13d ago
XENE
Xenon Files FDA NDA for Azetukalner in Focal Seizures and Pauses New Psychiatry Enrollment
Premium
Company Announcements
Xenon Files FDA NDA for Azetukalner in Focal Seizures and Pauses New Psychiatry Enrollment
14d ago
XENE
Xenon to Spotlight Azetukalner Phase 3 and Mechanistic Data at EEC 2026
Premium
Company Announcements
Xenon to Spotlight Azetukalner Phase 3 and Mechanistic Data at EEC 2026
1M ago
XENE
Xenon Pharmaceuticals’ Earnings Call Signals Pivotal NDA
Premium
Company Announcements
Xenon Pharmaceuticals’ Earnings Call Signals Pivotal NDA
1M ago
XENE
Xenon Therapeutics: Buy Rating Reiterated as AZK Progress and Strong Cash Position Support Compelling Risk-Reward; Price Target Maintained at $78
Premium
Ratings
Xenon Therapeutics: Buy Rating Reiterated as AZK Progress and Strong Cash Position Support Compelling Risk-Reward; Price Target Maintained at $78
2M ago
XENE
Xenon advances azetukalner toward planned U.S. NDA filing
Premium
Company Announcements
Xenon advances azetukalner toward planned U.S. NDA filing
2M ago
8K
XENE
XENE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
XENE Upcoming Earnings Report: What to Expect?
2M ago
XENE
More DE:XP0 News >

XP0 News on the Web

Xenon Pharmaceuticals Inc. at TD Cowen Novel Mechanisms in Neuropsychiatry Conference (Virtual) ...
GuruFocus News
Neutral
Xenon Pharmaceuticals (XENE) Seeks Epilepsy Approval. Can its Drug Overcome a Depression Setback?
Insider Monkey
Neutral
Minter Reiterates Buy on Xenon as Azetukalner NDA Progress and Manageable Neuropsychiatric Risk Underscore Favorable Risk‑Reward
TipRanks News
Bullish
Xenon Pharmaceuticals downgraded to Hold from Buy at Deutsche Bank
TipRanks News
Bearish
Xenon Pharmaceuticals (XENE) Shares Drop 22% After Enrollment Halt in Depression Trials
GuruFocus News
Bearish
Xenon sinks after pausing depression study enrollment
TipRanks News
Bearish
Xenon Slides As Safety Worry Shadows Seizure Drug
TipRanks News
Neutral
Wells Fargo Sticks to Its Buy Rating for Xenon (XENE)
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average11.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:XP0’s Media Buzz Sentiment?
Currently, no data Available
What is DE:XP0’s weekly average amount of articles?
In an average week, 11.25 articles about DE:XP0 are published.
    What is DE:XP0’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    SMMTSummit Therapeutics
    CDNACareDx
    ARGXArgenx Se
    MEOBFMesoblast Limited
    KODKodiak Sciences
    Showing the stocks with the most bullish news sentiment over the past week